info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » pharmaceuticals

pharmaceuticals

MEK Inhibitors Market By Molecule Type (Trametinib, Cobimetinib, Binimetinib, Selumetinib, Others); By Application (Melanoma, Non-Small Cell Lung Cancer, Colorectal Cancer, Neurofibromatosis Type 1, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online & Specialty Distributors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

MEK Inhibitors Market Overview and Growth Outlook (Last Updated on: June-2026)

The Global MEK Inhibitors Market is on a strong growth trajectory, expanding at a 9.4% CAGR, increasing from USD 3.2 billion in 2024 to USD 5.6 billion by 2030.

 

... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

SYK Inhibitors Market By Molecule Type (Small Molecule, Biologic); By Indication (Hematological Malignancies, Autoimmune Diseases, Inflammatory Disorders); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global SYK Inhibitors Market is expected to grow at a robust CAGR of 23.5%, estimated at $635 million in 2024 and projected to reach nearly Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Insulin Biosimilar Market By Product Type (Basal, Bolus, Premixed); By Disease Type (Type 1 Diabetes, Type 2 Diabetes); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Insulin Biosimilar Market is projected to expand steadily between 2024 and 2030, growing at an estimated CAGR of 9.1%, with market value expected to reach USD 7.8 ... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Anaplastic Lymphoma Kinase (ALK) Inhibitors Market By Drug Generation (First-Generation, Second-Generation, Third-Generation); By Application (Non-Small Cell Lung Cancer, Anaplastic Large Cell Lymphoma, Pediatric & Rare Cancers); By End User (Cancer Specialty Hospitals, General Hospitals, Outpatient Oncology Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anaplastic Lymphoma Kinase (ALK) Inhibitors Market is positioned for steady expansion over the next several years, with a robust Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

KRAS Inhibitors Market By Mutation Type (KRAS G12C, KRAS G12D, Other Mutations); By Cancer Type (NSCLC, Colorectal Cancer, Pancreatic Cancer, Other Cancers); By Drug Type (Monotherapy, Combination Therapy); By Route of Administration (Oral, Parenteral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global KRAS Inhibitors Market is projected to expand steadily over the next decade. Valued at roughly USD 2.1 billion in 2024, it is expected to surpass ... Read More

Published Date: DEC-2025 | No Of Pages:198 | $ 4485

Selective Estrogen Receptor Degrader (SERD) Market By Product Type (Injectable SERDs, Oral SERDs); By Route of Administration (Intramuscular, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Selective Estrogen Receptor Degrader (SERD) Market expanding at 8.9% CAGR, driven by clinical trials, breast cancer therapeutics, oncology drugsRead More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

CDC7 Kinase Inhibitors Drugs Market By Drug Type (Small Molecule Inhibitors, Combination Therapies); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Route of Administration (Oral, Intravenous); By End User (Academic Hospitals, Cancer Centers, Community Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CDC7 Kinase Inhibitors Drugs Market is projected to grow at a robust 18.2% CAGR, rising from $487 million in 2024 to $1.33 billion by 2030, driven by adva... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

PROTAC Inhibitors Market By Type (Bifunctional PROTACs, Molecular Glue Degraders); By Therapeutic Area (Oncology, Neurodegenerative Diseases, Autoimmune Disorders); By End User (Academic & Research Institutes, Specialty Oncology Centers, CROs, Pharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PROTAC Inhibitors Market is projected to expand at a robust 28.7% CAGR, rising from USD 417 million in 2024 to over USD 1.9 billion by 2030, driven by adv... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

STAT3 Inhibitors Market By Drug Type (Small Molecule Inhibitors, Antisense Oligonucleotides, Peptides, Protein Degraders); By Route of Administration (Oral, Injectable, Localized/Intratumoral); By Application (Oncology, Inflammatory Diseases, Fibrosis, Autoimmune Disorders); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global STAT3 Inhibitors Market is projected to grow at a 6.5% CAGR from USD 410.0 million in 2024 to over USD 600.0 million by 2030, driven by advances in target... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

mTOR Inhibitors Market By Product Type (Rapamycin Derivatives [Sirolimus, Everolimus, Temsirolimus], Next-Generation mTOR Inhibitors); By Therapeutic Indication (Oncology, Immunosuppressive Therapy, Rare Genetic Disorders); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Specialty Cancer Centers, Transplant Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mTOR Inhibitors Market valued at USD 7.2 billion in 2024 and forecast to USD 11.5 billion by 2030 at 8.1%, CAGR, fueled by market size, <... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

C5 Complement Inhibitors Drug Market By Drug Type (Monoclonal Antibodies, RNAi-based Therapies, Small Molecules & Novel Modalities); By Route of Administration (Intravenous, Subcutaneous, Oral Administration [Pipeline]); By Indication (PNH, aHUS, gMG, Neurological & Renal Disorders [Pipeline], Other Neurological and Renal Autoimmune Disorders); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

C5 Complement Inhibitors Drug Market: Market Intelligence Snapshot (Last Updated on: June-2026)

The Global C5 Complement Inhibitors Drug Market is valued at USD 9.8 billion in 2024 and projected to reach USD 16.7 billion by 2030, exp... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

GPRC5D Targeting Drugs Market By Therapy Type (Bispecific Antibodies, CAR-T Cell Therapies, Antibody-Drug Conjugates); By Indication (Relapsed/Refractory Multiple Myeloma, High-Risk/Smoldering Myeloma, Solid Tumors); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global GPRC5D Targeting Drugs Market is projected to witness a robust CAGR of 36.5%, with an estimated valuation of USD 487 million in 2024, expected to surpass USD 3.2 b... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

TRK Inhibitors Market By Drug Type (First-generation TRK inhibitors, Next-generation TRK inhibitors); By Cancer Indication (Non-small cell lung cancer, Soft tissue sarcoma, Thyroid cancer, Pediatric tumors, Others); By End User (Oncology centers, Academic hospitals, Community hospitals, Diagnostic labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TRK Inhibitors Market is projected to grow at a robust 12.6% CAGR, rising from USD 3.1 billion in 2024 to USD 6.4 billion by 2030, driven by expanding NTR... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

ATR Protein Inhibitors Market By Drug Type (Oral, Intravenous); By Application (Solid Tumors [Ovarian, Lung, Breast, Pancreatic], Hematologic Malignancies); By Combination Regimen (Monotherapy, Combination Therapy [PARP Inhibitors, Immunotherapy]); By End User (Academic Hospitals, Community Oncology Centers, Specialty Clinics); By Region, Segment Revenue Estimation, Forecast, 2024–2030

ATR Inhibitors Market Advances as DNA Damage Response Pipelines Target Replication Stress and Therapy-Resistant Tumors (Last Updated on: June-2026)

The Global ATR Protein Inhibitors Market is projected to grow at a robust 14.8% CAGR, rising from&nb... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

RET Inhibitors Drug Market By Drug Type (Selective RET Inhibitors, Multikinase Inhibitors); By Indication (NSCLC, Thyroid Cancer, Other RET-Altered Tumors); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RET Inhibitors Drug Market will witness a robust CAGR of 12.3%, valued at an estimated USD 3.2 billion in 2024, and projected to reach ar... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

MCL1 Inhibitor Drugs Market By Drug Type (Small Molecule Inhibitors, Biologics/Peptide-Based Agents); By Indication (Hematologic Malignancies [AML, CLL, Multiple Myeloma], Solid Tumors [NSCLC, TNBC, Pancreatic Cancer]); By Route of Administration (Oral, Intravenous); By End User (Tertiary Cancer Centers, Oncology Networks, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global MCL1 Inhibitor Drugs Market valued at USD 672 million in 2024 and forecast to reach USD 1.45 billion by 2030 with 13.4% CAGR, shaped by oncology d... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Atypical Hemolytic Uremic Syndrome Market By Drug Class (C5 Inhibitors, C3 Inhibitors, MASP-2 Inhibitors, RNAi Therapies, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Platforms); By End User (Hospitals, Specialty Clinics, Pediatric Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Atypical Hemolytic Uremic Syndrome (Ahus) Market will witness a steady Compound Annual Growth Rate (CAGR) of 7.8... Read More

Published Date: DEC-2025 | No Of Pages:184 | $ 4485

Aromatase Inhibitors Market By Drug Type (Anastrozole, Letrozole, Exemestane); By Application (Breast Cancer, Ovarian Cancer, Male Breast Cancer, Endometriosis, Fertility Treatment – PCOS); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Aromatase Inhibitors Market: How Breast Cancer Therapy and Prevention Use Shape Demand

The Global Aromatase Inhibitors Market is projected to grow from USD 2.7 billion in 2024 to USD 3.8 billion by 2030, expanding at ... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Angiotensin-Converting Enzyme (ACE) Inhibitors Market By Product Type (Lisinopril, Enalapril, Ramipril, Captopril, Benazepril, Others); By Application (Hypertension, Heart Failure, Myocardial Infarction, Diabetic Nephropathy, CKD, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

ACE Inhibitors Market: Rising Hypertension and Cardiometabolic Burden Driving Long-Term Generic Drug Demand (Last Updated On: June-2026)

The Global Angiotensin-Converting Enzyme Inhibitors Market is projected to expand at a CAGR of 5.8%, ... Read More

Published Date: DEC-2025 | No Of Pages:186 | $ 4485

Alpha-synuclein Inhibitors Market By Drug Class (Small Molecules, Monoclonal Antibodies, Peptide Inhibitors); By Mechanism of Action (Aggregation Inhibitors, Misfolding Blockers, Clearance Enhancers); By Indication (Parkinson’s Disease, Multiple System Atrophy, Lewy Body Dementia); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha-Synuclein Inhibitors Market is projected to grow at a strong 21.8% CAGR, rising from USD 1.2 billion in 2024 to USD 3.9 billion by 2030, driven by a... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

TIM3 Inhibitors Drug Market By Molecule Type (Monoclonal Antibodies, Small Molecules, Fusion Proteins, Bispecific Antibodies); By Indication (Solid Tumors, Hematologic Malignancies, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Academic Hospitals, Cancer Institutes, Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TIM3 Inhibitors Drug Market is poised for notable expansion over the forecast period, with an CAGR of 16% between 2024 and 2030, The market is estimated t... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

GABA Receptor Agonist Market By Product Type (Benzodiazepine-Based Agonists, Barbiturates, Gabapentinoids, Allosteric Modulators); By Therapeutic Application (Epilepsy, Anxiety & Mood Disorders, Sleep Disorders, Spasticity, Neuropathic Pain); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

GABA Receptor Agonist Market Evolves Through Neurosteroids, CNS Safety and Subtype-Selective Modulation (Last Updated on: June-2026)

The Global GABA Receptor Agonist Market will witness a robust CAGR of 6.8%, valued at USD ... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Push-in Plug Vials Market By Material Type (Glass, Plastic); By Capacity (<5 ml, 5–20 ml, >20 ml); By Application (Parenteral Delivery, Oral Liquids, Clinical Sampling, Diagnostics, Compounding); By End User (Pharmaceutical Manufacturers, CDMOs, Compounding Pharmacies, Diagnostic Labs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Push-In Plug Vials Market is expected to grow steadily over the forecast period, with an CAGR of 5.8% , reaching an estimated market value of USD 734.6 million by 2030 fro... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Sterilization Tunnel Market By Technology Type (Dry Heat Sterilization Tunnels, Infrared Sterilization Tunnels); By Application (Pharmaceutical Manufacturing, Biotechnology, Food & Beverage); By End User (Large Pharmaceutical Companies, CDMOs, Biotech Firms, Food Producers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sterilization Tunnel Market is projected to expand steadily, valued at around USD 1.2 billion in 2024 and anticipated to reach approximately USD 1.9 billion by 203... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Antimalarial Drugs Market By Product Type (Artemisinin-based Combination Therapies, Chloroquine & Derivatives, Quinine & Alkaloids, Novel/Next-Gen Drugs); By Route of Administration (Oral, Parenteral, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Government & NGO Procurement); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antimalarial Drugs Market will expand at an estimated CAGR of 6.3%, valued at around USD 4.1 billion in 2024, and projected to reach USD ... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Anti-Ageing Drugs Market By Drug Type (Metabolic Modulators, Hormonal Therapies, NAD+ Precursors, Antioxidants, Senolytics); By Route of Administration (Oral, Injectable, Transdermal); By Distribution Channel (Prescription Pharmacies, Retail Pharmacies & Wellness Clinics, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Anti-Ageing Drugs Market: Longevity Science, Age-Related Disease Therapies, and Geroscience Pipelines Redefine Healthy-Ageing Medicine

The Global Anti-Ageing Drugs Market is estimated at USD 47.2 billion in 2025 and is projected to reach USD 76.8 billion by 2032, regi... Read More

Published Date: JUN-2026 | No Of Pages:196 | $ 4485

Fragment Based Drug Discovery Market By Technique (X-ray Crystallography, NMR Spectroscopy, SPR, ITC, Others); By Service Type (Fragment Screening, Hit-to-Lead Optimization, Library Design, Custom Assays, Computational Modeling); By Therapeutic Area (Oncology, CNS Disorders, Infectious Diseases, Autoimmune, Rare Disorders); By End User (Pharmaceutical Companies, Biotech Firms, Academic & Research Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fragment Based Drug Discovery Market USD 1.21 billion in 2024 to USD 2.73 billion by 2030 at 14.5% CAGR, led by fragment based drug discovery mark... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Botulinum Toxin Market By Product Type (Botulinum Toxin Type A, Botulinum Toxin Type B); By Application (Aesthetic, Therapeutic – Neurology, Urology, Gastroenterology, Pain, Others); By End User (Hospitals, Specialty Clinics, Aesthetic Centers, Ambulatory Surgical Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Botulinum Toxin Market is projected to grow from USD 11.2 billion in 2024 to USD 17.6 billion by 2030, registering a 7.8% CAGR, driven by rising therapeut... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Drug Bioavailability Enhancement Market By Product Type (Solubility Enhancers, Permeability Enhancers, Metabolism Modifiers); By Route of Administration (Oral, Transdermal, Nasal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Drug Bioavailability Enhancement Market: Poor Solubility, BCS Class II/IV Risk, and Reformulation Economics Drive Exposure-Optimized Drug Development

The Global Drug Bioavailability Enhancement Market was valued at USD 3.9 billion in 2025 and is projected to reach USD... Read More

Published Date: JUN-2026 | No Of Pages:158 | $ 4485

SARM1 Inhibitors Market By Application (ALS, Peripheral Neuropathies, Traumatic Brain & Spinal Cord Injuries, MS, Chemotherapy-Induced Neuropathy, Others); By Molecule Type (Small Molecule Inhibitors, Biologics & Peptides, Gene & RNA-based Approaches); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

SARM1 Inhibitors Market Advances as Axon-Protection Pipelines Target Neuropathy and Neurodegeneration (Last Updated on: June-2026)

The Global SARM1 Inhibitors Market is projected to register strong growth at a CAGR of 28.5%, increasing from USD 120 million in 202... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Injection Bottle Market By Product Type (Sterile Injection Bottles, Non-Sterile Injection Bottles); By Material (Glass, Polymer); By Capacity (<10 ml, 10–50 ml, >50 ml); By End User (Pharmaceutical Companies, CMOs, Hospitals, Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Injection Bottle Market growing from USD 9.7 billion in 2024 to USD 13.6 billion by 2030 with 5.8% CAGR, reflecting market size, ... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Orphan Drugs Market By Drug Type (Biologics, Non-Biologics); By Therapy Area (Oncology, Neurology, Metabolic & Endocrine Disorders, Others); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orphan Drugs Market is forecast to register a steady CAGR of 9.6%, growing from USD 175.2 billion in 2024 to nearly USD 305.4 billion by 2030, supported b... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Ticagrelor Market By Product Type (Branded, Generic); By Indication (Acute Coronary Syndrome, Myocardial Infarction Prevention, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ticagrelor Market is projected to expand steadily between 2024 and 2030, growing at a CAGR of 6.1% , valued at around USD 2.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Psychedelic Drugs Market By Drug Type (Psilocybin, MDMA, Ketamine, LSD & Others); By Application (Depression, PTSD, Addiction, Anxiety); By Distribution Model (Clinic-Based Therapy, Hospital Pharmacies, Home Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Psychedelic Drugs Market is projected to expand steadily between 2024 and 2030, with an CAGR of 13.5% , valued at around USD 5.1 billion in 2024 and expec... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Ophthalmic Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV); By Study Design (Interventional, Observational, Adaptive/Hybrid); By Indication (Age-Related Macular Degeneration, Glaucoma, Diabetic Retinopathy, Dry Eye, Rare Retinal Disorders); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmic Clinical Trials Market expanding to USD 6.1 billion by 2030 from USD 3.8 billion in 2024 at 7.9% CAGR growth, shaped by market size dyn... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Therapeutic Vaccines Market By Disease Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Neurological Conditions); By Technology (Dendritic Cell Vaccines, Tumor Cell Vaccines, DNA-based Vaccines, mRNA Vaccines, Viral Vector Vaccines, Protein/Peptide Vaccines); By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Therapeutic Vaccines Market will grow steadily at a CAGR of 7.8%, rising from USD 21.6 billion in 2024 to USD 34.1 billion by 2030, fueled by canc... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Anti-CD47 Drugs Market By Drug Type (Monoclonal Antibodies, Bispecific Antibodies, SIRPα-Fc Fusion Proteins, Small Molecules & Other Next-Generation CD47/SIRPα Modulators); By Application (Hematologic Malignancies [Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, T-Cell Lymphoma / Peripheral T-Cell Lymphoma], Solid Tumors [Gastric / Gastroesophageal Junction Cancer, Breast Cancer, Colorectal Cancer, Head & Neck Cancer, Lung Cancer, Other Solid Tumors]); By End User (Academic Cancer Centers, Oncology Hospitals, Specialty Oncology Clinics, Clinical Research Institutes & Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Anti-CD47 Drugs Market: Biomarker-Led Solid Tumor Strategies Replace the Broad Hematology Launch Thesis

The Global Anti-CD47 Drugs Market was valued at USD 0.23 billion in 2025 and is expected to reach USD 2.36 billion by 2032, registering a 39.5% CAGR.

&nbs... Read More

Published Date: JUL-2026 | No Of Pages:178 | $ 4485

RSV Vaccine Market By Vaccine Type (Subunit Vaccines, Live-Attenuated Vaccines, mRNA Vaccines); By Target Population (Older Adults, Pregnant Women, Infants & Children, Immunocompromised Individuals); By Route of Administration (Intramuscular, Intranasal); By Distribution Channel (Hospital Pharmacies, Retail Clinics, Public Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RSV Vaccine Market valued at USD 2.1 billion in 2024 and expected to grow to USD 5.0 billion by 2030 at 15.6% CAGR, propelled by RSV vaccineRead More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

PCSK9 Inhibitor Market By Drug Type (Monoclonal Antibodies, siRNA Therapies); By Indication (ASCVD, Familial Hypercholesterolemia, Statin Intolerance); By Route of Administration (Subcutaneous Injection, Long-Interval Injection); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PCSK9 Inhibitor Market forecasting USD 9.3 billion by 2030 from USD 5.1 billion in 2024 at 10.1% CAGR, supported by PCSK9 inhibitor market sizeRead More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Drug Reconstitution Market By Product Type (Dual-Chamber Vials, Dual-Chamber Syringes and Cartridges, Dual-Chamber IV Bags, Reconstitution Transfer Devices, Automated Reconstitution Devices, Ready-to-Administer Prefilled Syringes, Reconstitution-Enabled Autoinjectors, Reconstitution-Enabled Wearable Injectors, Others); By Drug Form (Lyophilized Injectable Drugs, Powder Injectable Drugs, Concentrated Injectable Drugs, Two-Component Injectable Products, Others); By Application (Vaccines, Biologics and Biosimilars, Oncology Drugs, Antibiotics and Anti-Infectives, Specialty Injectables, Emergency and Critical Care Injectables, Others); By End User (Hospitals, Hospital Pharmacies, Specialty Clinics, Ambulatory Care Centers, Home Healthcare Settings, Pharmaceutical and Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, Others); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Drug Reconstitution Market: Injectable Safety, Lyophilized Biologics, Dual-Chamber Systems, and Ready-to-Administer Formats Shift Value Away from Manual Mixing

The Global Drug Reconstitution Market will witness a steady CAGR of 7.24%, valued at USD 4.7 billion in 2025... Read More

Published Date: JUL-2026 | No Of Pages:194 | $ 4485

Growth Hormone Deficiency Market By Treatment Type (Daily Recombinant Growth Hormone Therapy, Long-Acting Weekly Growth Hormone Therapy, Emerging Growth Hormone Secretagogues and Investigational Therapies); By Patient Type (Pediatric Growth Hormone Deficiency, Adult Growth Hormone Deficiency); By Distribution Channel (Hospital Pharmacies, Retail and Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Growth Hormone Deficiency Market: Diagnosis Expansion and Weekly Therapy Reshape a Mature Endocrine Category

The Global Growth Hormone Deficiency Market was valued at USD 4.92 billion in 2025 and is projected to reach USD 7.02 billion by 2032, expanding at a CAGR of 5... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Brain Tumor Drugs Market By Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy, Corticosteroids); By Tumor Type (Glioblastoma, Astrocytoma, Medulloblastoma, Pituitary Tumors, Others); By Route of Administration (Oral, Injectable, Implantable); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brain Tumor Drugs Market will witness a solid CAGR of 8.5%, valued at USD 3.6 billion in 2024 and projected to reach Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

TIGIT Inhibitors Market By Therapy Type (Monotherapy, Combination Therapy); By Cancer Indication (NSCLC, Triple-Negative Breast Cancer, Melanoma, Head & Neck Cancer, Others); By Route of Administration (Intravenous, Others); By End User (Academic Cancer Centers, Oncology Clinics, CROs, Specialty Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

TIGIT Inhibitors Market Repositions Around Clinical Validation After Mixed Late-Stage Immuno-Oncology Readouts (Last Updated on: June-2026)

The Global TIGIT Inhibitors Market is projected to grow at a strong CAGR of 22.6% during the forecast period. The market was val... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Cytotoxic Drugs and HPAPI Manufacturing Market By Product Type (Cytotoxic Drugs, HPAPIs); By Application (Oncology, Autoimmune Disorders, Others); By Manufacturing Approach (In-House Manufacturing, Outsourced Manufacturing); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cytotoxic Drugs and HPAPI Manufacturing Market is expected to register a CAGR of 8.6%, growing from USD 21.7 billion in 2024 to USD 35.6 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Complement Inhibitors Market By Product Type (Monoclonal Antibodies, Small Molecules, RNA-based Therapies, Others); By Indication (Hematology, Nephrology, Neurology, Ophthalmology, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online/Direct Distribution); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Complement Inhibitors Market is anticipated to register a steady CAGR of 9.8%, expanding from USD 8.6 billion in 2024 to USD 15.1 billion by 2030, support... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

EZH2 Inhibitors Market By Drug Type (Tazemetostat, CPI-1205, Valemetostat, Others); By Indication (Follicular Lymphoma, Epithelioid Sarcoma, Prostate Cancer, Others); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global EZH2 Inhibitors Market is poised for strong momentum at a CAGR of 17.9%, valued at USD 815.2 million in 2024 and projected to reach USD 2.19 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Antiemetics Drugs Market By Drug Class (5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Dopamine Antagonists, Cannabinoids & Others); By Application (Chemotherapy-Induced Nausea and Vomiting, Post-Operative Nausea and Vomiting, Motion Sickness & Gastroenteritis, Pregnancy-Induced Nausea); By Route of Administration (Oral, Injectable, Transdermal & Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antiemetics Drugs Market is projected to expand steadily between 2024 and 2030. The market is valued at USD 6.8 billion in 2024 and is expected to reach <... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Pulmonary Arterial Hypertension Market By Drug Class (Endothelin Receptor Antagonists, Prostacyclin & Prostacyclin Analogs, Phosphodiesterase-5 Inhibitors, Soluble Guanylate Cyclase Stimulators, Emerging Therapies); By Route of Administration (Oral, Injectable, Inhaled); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Arterial Hypertension (PAH) Market is projected to grow steadily between 2024 and 2030, moving from USD 8.7 billion in 2024 to approximately USD 13.5 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:176 | $ 4485

Specialty Generics Market By Product Type (Injectables, Oral Modified-Release Formulations, Inhalable Generics, Ophthalmic Generics, Others); By Therapeutic Area (Oncology, Autoimmune Disorders, Cardiology & Respiratory, Neurology, Others); By Route of Administration (Injectable, Oral, Inhalation, Topical & Ophthalmic); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Specialty Generics Market is forecast to grow at a CAGR of 8.1%, valued at USD 75.6 billion in 2024 and projected to reach USD 120.8 billion by 2030, supp... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Tramadol Market By Product Type (Immediate-Release, Extended-Release, Injectable, Combination Drugs); By Application (Orthopedic Pain, Cancer Pain, Post-Surgical Pain, Neuropathic Pain); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tramadol Market will expand at a CAGR of 6.5%, valued at USD 2.4 billion in 2024, and expected to reach USD 3.50 billion by 2030, driven by pain m... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Bevacizumab Biosimilars Market By Indication (Colorectal Cancer, Lung Cancer, Renal Cell Carcinoma, Others); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online & Retail Pharmacies); By End User (Large Hospitals & Cancer Institutes, Community Oncology Clinics, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bevacizumab Biosimilars Market will witness a robust CAGR of around 17.0 %, valued at approximately USD 3.6 billion in 2024, expected to ... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Wound Gel Market By Product Type (Hydrogel-Based, Antimicrobial, Alginate-Based, Collagen-Based); By Wound Type (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical Wounds, Burns, Traumatic Wounds); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Wound Gel Market valued at $1.58 billion in 2024 and projected to reach $2.26 billion by 2030 at 6.2% CAGR, reflecting medical wound gels... Read More

Published Date: DEC-2025 | No Of Pages:158 | $ 4485

Hyaluronidase Market By Product Type (Animal-Derived, Recombinant); By Route of Administration (Subcutaneous, Intravenous, Topical); By Application (Aesthetic Procedures, Oncology, Ophthalmology, Orthopedics, Drug Delivery); By End User (Hospitals, Specialty Clinics, Cosmetic Dermatology Centers, Research Labs, Biopharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyaluronidase Market expanding at 7.8% CAGR, forecast to hit USD 1.5 billion by 2030 from USD 940 million in 2024, supported by tissue permeabilit... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Contraceptive Drugs Market By Product Type (Combined Hormonal Contraceptives, Progestin-Only Contraceptives, Emergency Contraceptives, Other Hormonal Therapies); By Route of Administration (Oral, Injectable, Transdermal & Vaginal, Implants & IUS); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Family Planning Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Contraceptive Drugs Market will expand at a steady pace between 2024 and 2030, with an estimated value of USD 16.9 billion in 2024 and projected to reach around US... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Dental Cleansing Tablet Market By Product Type (Standard Effervescent Tablets, Multi-Action Tablets, Natural and Eco-Friendly Tablets); By Application (Dentures, Orthodontic Aligners & Retainers, Sports Mouthguards & Sleep Appliances); By Distribution Channel (Retail Pharmacies, Online/E-commerce, Supermarkets & General Retail); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dental Cleansing Tablet Market is expected to expand at a CAGR of 6.8%, starting from USD 3.2 billion in 2024 and reaching USD 4.7 billion by 2030, driven... Read More

Published Date: DEC-2025 | No Of Pages:176 | $ 4485

Vyvgart (Efgartigimod) Market By Indication (gMG, CIDP, ITP, Pemphigus Vulgaris & Foliaceus, Myositis, Nephrology Disorders); By Route of Administration (Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Outpatient Clinics, Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vyvgart (Efgartigimod) Market is projected to grow at a CAGR of 32.8% , reaching approximately USD 6.1 billion b... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Pharmaceutical Isolator Market By Type (Open Isolators, Closed Isolators, Modular & Robotic Isolators); By Application (Sterile Manufacturing, Research & Development, Quality Control & Testing, Cytotoxic & HPAPI Handling); By End User (Pharmaceutical & Biotechnology Companies, CDMOs, Academic & Research Institutes, Hospitals & Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Isolator Market is forecast to witness steady growth between 2024 and 2030, expanding from USD 6.2 billion in 2024 to USD 9.8 billion by 2030, at a ... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Small Molecule CDMO Market By Service Type (API Development & Manufacturing, Drug Product Formulation, Packaging Services); By Molecule Type (Innovative Small Molecules, Generic Small Molecules); By Phase of Development (Early-Phase Development, Late-Phase and Commercial Manufacturing); By End User (Large Pharmaceutical Companies, Mid-Sized Pharma, Emerging Biotech, Generic & Specialty Pharma); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule CDMO Market will grow from USD 67.5 billion in 2024 to nearly USD 108.4 billion by 2030, advancing at a CAGR of 8.2%, driven by pha... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Drug Discovery Outsourcing Market By Service Type (Preclinical Services, Clinical Trials Services, Discovery Chemistry & Biology Services, Regulatory and Clinical Development Services); By Therapeutic Area (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic & Research Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Discovery Outsourcing Market is projected to increase from USD 9.4 billion in 2024 at a sustained CAGR of 7.2% until 2030, attaining USD 14.3 billion by 2030<... Read More

Published Date: NOV-2025 | No Of Pages:154 | $ 4485

Artificial Tears Market By Product Type (Preservative-Free, Gel-Based, Traditional); By Distribution Channel (Retail Pharmacies, Online, Hospitals and Clinics); By End User (Individuals with Dry Eye Disease, Healthcare Providers, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Artificial Tears Market is expected to grow from USD 4.5 billion in 2024 to USD 7.63 billion by 2030, registering a CAGR of 9.2%, supported by rising adop... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Dry Powder Inhaler Market By Product Type (Single-Dose Inhalers, Multi-Dose Inhalers, Pre-filled Inhalers); By Application (Asthma, COPD, Other Pulmonary Diseases); By End User (Hospitals, Clinics, Homecare, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dry Powder Inhaler Market is expanding due to increasing prevalence of chronic respiratory conditions, asthma management, COPD treatment devices, ... Read More

Published Date: NOV-2025 | No Of Pages:185 | $ 4485

Small Molecule Drug Discovery Market By Discovery Stage (Target Identification and Validation, Hit Identification, Hit-to-Lead, Lead Optimization, Preclinical Candidate Selection); By Technology and Service (High-Throughput Screening, Structure-Based Drug Design, Fragment-Based Drug Discovery, Virtual Screening and AI-Enabled Design, Medicinal Chemistry, ADME and Toxicology Support); By Therapeutic Area (Oncology, Infectious Diseases, Neurology and Psychiatry, Cardiovascular and Metabolic Disorders, Immunology, Rare Diseases, Others); By End User (Pharmaceutical Companies, Biotechnology Companies, CROs and CRDMOs, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Small Molecule Drug Discovery Market: AI-Enabled Chemistry, Targeted Oral Therapies, and Patent-Cliff Pressure Rebuild Pharma’s Core Discovery Engine

The Global Small Molecule Drug Discovery Market is set to expand from USD 68.54 billion in 2025 to USD 128.6 bil... Read More

Published Date: JUL-2026 | No Of Pages:155 | $ 4485

Cold Form Blister Packaging Market By Material Type (Aluminum Foil, PVC/Polyamide, Multilayer Films); By Application (Prescription Pharmaceuticals, OTC Drugs & Supplements, Diagnostic Kits, Others); By End User (Pharmaceutical Manufacturers, Nutraceutical Brands, Diagnostic Kit Makers, Contract Packaging Organizations); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cold Form Blister Packaging Market is estimated to expand at a CAGR of 6.2%, reaching about USD 8.6 billion by 2030 from USD 5.9 billion in 2024, supporte... Read More

Published Date: NOV-2025 | No Of Pages:154 | $ 4485

Glucosamine Market By Product Type (Glucosamine Sulfate, Glucosamine Hydrochloride, N-Acetylglucosamine); By Application (Osteoarthritis Treatment, Sports Nutrition, Skin Health); By End-User (Pharmaceutical & Biotech Companies, Healthcare Providers, Retail & Online Consumers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Glucosamine Market is projected to grow at a robust pace, with an expected CAGR of 6.2% from 2024 to 2030. The market, valued at USD 7.5 billion in 2024, is poised to reac... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Plant-Based API Market By Product Type (Herbal APIs, Botanical APIs); By Application (Cardiovascular Diseases, Diabetes, Oncology, Metabolic Disorders, Others); By End-User (Pharmaceutical & Biotech Companies, CMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Plant-Based API Market is poised for strong expansion. Valued at USD 4.2 billion in 2024, it is projected to reach USD 7.6 billion by 2030, growing at a CAGR of 11... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

3D Printed Drugs Market By Technology (Fused Deposition Modeling, Inkjet Printing, Stereolithography); By Application (Personalized Medicine, On-Demand Drug Manufacturing, Oral Solid Dosage Development); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutions, Hospitals & Compounding Pharmacies, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global 3D Printed Drugs Market is projected to grow at a remarkable CAGR of 16.2%, from $410 million in 2024 to $1.04 billion by 2030, driven by technological ad... Read More

Published Date: NOV-2025 | No Of Pages:190 | $ 4485

Generic Oncology Drugs Market By Drug Class (Cytotoxic Chemotherapy Generics, Targeted Therapy Generics, Hormonal Therapy Generics, Supportive Care Generics, Oncology Biosimilars); By Molecule Type (Small-Molecule Generics, Biosimilars); By Route of Administration (Injectable / Parenteral, Oral); By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Leukemia, Lymphoma, Prostate Cancer, Ovarian Cancer, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2026–2032

Generic Oncology Drugs Market: Patent Cliffs, Biosimilar Cost Relief, and Supply-Chain Resilience Reshape Cancer Treatment Economics

The Global Generic Oncology Drugs Market was valued at USD 28.14 billion in 2025 and is projected to reach USD 47.99 billion by 2032, e... Read More

Published Date: JUN-2026 | No Of Pages:177 | $ 4485

Cannabis Testing Market By Testing Type (Potency Testing, Contaminant Testing, Terpene Testing, Residual Solvent Testing); By Methodology (Chromatography, Mass Spectrometry, Immunoassays); By End-User (Cannabis Producers, Dispensaries, Research Organizations, Government & Regulatory Bodies, Consumers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Testing Market is expected to grow steadily from USD 2.5 billion in 2024 to USD 7.6 billion by 2030, with a robust CAGR of 15.2%, driven by incre... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Lyophilized Injectable Drugs Market By Product Type (Biologics, Chemotherapeutic Drugs, Hormones, Other Injectable Drugs); By Application (Oncology, Infectious Diseases, Endocrinology, Other Therapeutic Areas); By End User (Pharmaceutical & Biotech Companies, Contract Manufacturing Organizations, Hospitals & Clinics, Research Institutions); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lyophilized Injectable Drugs Market is poised for significant growth from 2024 to 2030, projected to expand at a CAGR of 8.5%. Valued at USD 12.3 billion in 2024, it is ex... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Prefilled Formalin Vials Market By Product Type (Single-Use Prefilled Vials, Reusable Prefilled Vials); By Application (Medical & Clinical Diagnostics, Forensic Science, Research & Development); By End User (Hospitals & Healthcare Providers, Research Institutes & Laboratories, Contract Research Organizations, Forensic Laboratories); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Prefilled Formalin Vials Market is forecasted to grow at a steady CAGR of 6.5%, rising from USD 400 million in 2024 to USD 600 million by 2030, propelled ... Read More

Published Date: NOV-2025 | No Of Pages:161 | $ 4485

Cyclooxygenase-2 (COX-2) Inhibitor Market By Product Type (Prescription, OTC); By Application (Osteoarthritis, Rheumatoid Arthritis, Acute Pain, Other Inflammatory Diseases); By End User (Pharmaceutical Companies, Hospitals, Retail Pharmacies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclooxygenase -2 (COX -2) Inhibitor Market is projected to grow steadily, with a CAGR of 4.2% , valued at USD ... Read More

Published Date: NOV-2025 | No Of Pages:170 | $ 4485

Softgel Capsules Market By Product Type (Standard Softgel Capsules, Specialty Softgel Capsules); By Application (Pharmaceuticals, Nutraceuticals, Cosmetics and Personal Care); By End User (Pharmaceutical Companies, Nutraceutical Companies, CMOs, Cosmetics and Personal Care Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Globa l Softgel Capsules Market is poised for steady growth, with a CAGR of approximately 7.5 % , valued at USDRead More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Enteric Softgel Capsules Market By Product Type (Gelatin-Based, Vegetable-Based); By Application (Pharmaceuticals, Nutraceuticals, Cosmetics); By End User (Pharmaceutical Companies, Nutraceutical Companies, CROs, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Enteric Softgel Capsules Market is expected to experience steady growth, with a projected CAGR of 6.2% from 2024 to 2030, rising from a v... Read More

Published Date: NOV-2025 | No Of Pages:166 | $ 4485

Oral and Topical Anaesthetics Market By Product Type (Oral Anaesthetics, Topical Anaesthetics); By Application (Dental Procedures, Dermatology, Emergency Medicine, Other Applications); By End User (Dental Clinics, Dermatology Clinics, Hospitals, OTC Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oral and Topical Anaesthetics Market is set to experience notable growth in the coming years, with a projected CAGR of 5.8% from 2024 to 2030. In Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Coccidioidomycosis Market By Treatment Type (Antifungal Drugs, Vaccines); By Diagnostic Method (PCR, Serology, Imaging); By End-User (Hospitals, Pharmaceutical Companies, Research Institutes); By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Coccidioidomycosis Market stands at USD 1.6 billion in 2024 and is expected to reach USD 2.7 billion by 2030, expanding at a CAGR of 6.3%, fueled by Read More

Published Date: NOV-2025 | No Of Pages:199 | $ 4485

Pharmaceutical Grade Lactose Market By Product Type (Anhydrous Lactose, Monohydrate Lactose); By Application (Oral Solid Dosage Forms, Inhalation Drugs, Others); By End User (Pharmaceutical Manufacturers, CROs, Generic Drug Manufacturers, Academic & Research Institutions, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Grade Lactose Market is projected to witness steady growth, with a compound annual growth rate (CAGR) of 4.2% , valued at USD 2.3 b... Read More

Published Date: NOV-2025 | No Of Pages:200 | $ 4485

Rapid Acting Insulin Market By Product Type (Branded Insulin, Generic Insulin); By Administration Route (Injection Pens, Insulin Pumps, Others); By End-User (Hospitals, Home Care Settings, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rapid Acting Insulin Market is projected to expand at a healthy CAGR of 6.5%, growing from USD 16.5 billion in 2024 to USD 24.5 billion by 2030, fueled by... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Chondroitin Sulfate Market By Source Type (Bovine, Shark, Porcine, Plant-Based); By Application (Dietary Supplements, Pharmaceuticals, Veterinary Medicine, Cosmetics); By End User (Consumers, Healthcare Providers, Veterinary Clinics, Cosmetic Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chondroitin Sulfate Market is poised for steady growth, driven by the increasing demand for joint health supplements and the expanding therapeutic applications of chondroi... Read More

Published Date: NOV-2025 | No Of Pages:195 | $ 4485

Albumin Market By Product Type (Human Albumin, Recombinant Albumin); By Application (Plasma Volume Expanders, Drug Delivery Systems, Diagnostic Reagents); By End User (Hospitals, Pharmaceutical & Biotech Companies, Research Laboratories, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Albumin Market continues to gain momentum due to increasing adoption in drug delivery platforms, plasma-derived medicines, biologics manufacturing, Read More

Published Date: NOV-2025 | No Of Pages:173 | $ 4485

Throat Lozenges Market By Product Type (Medicated, Non-Medicated); By Active Ingredients (Menthol, Honey & Herbal Extracts, Others); By Distribution Channel (Pharmacies & Drug Stores, Online Retail, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Throat Lozenges Market will experience steady growth during the forecast period from 2024 to 2030, with a projected CAGR of 5.6 % , estimated to reach a market value of Read More

Published Date: NOV-2025 | No Of Pages:172 | $ 4485

Anti-Infective Agents Market By Product Type (Antibiotics, Antivirals, Antifungals, Antiparasitic Drugs); By Therapeutic Class (Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, HIV Antivirals, Antimalarial Agents, Antifungal Agents); By Infection Type (Respiratory, Urinary Tract, Gastrointestinal, Skin, STIs, Others); By End-User (Hospitals, Clinics, Long-Term Care Facilities, Pharmaceutical Companies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anti-Infective Agents Market will experience significant growth from USD 82.3 billion in 2024 to approximately USD 120.5 billion by 2030 , driven by a rob... Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Skin Barrier Market By Product Type (Wipes & Films, Creams & Ointments, Sprays & Liquid Barriers); By Application (Ostomy Care, Wound Care, Incontinence Management, Dermatological Conditions); By End User (Hospitals & Clinics, Home Healthcare, Nursing Homes, Retail Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Skin Barrier Market will witness a steady CAGR of 6.64 % , valued at around USD 1.4 billion in 2024 , and is forecast to reach USD 2.1 billion by ... Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Chromatography Accessories and Consumables Market By Product Type (Columns, Syringe Filters, Vials and Caps, Reagents and Solvents, Tubing and Fittings); By Chromatography Technique (Liquid Chromatography, Gas Chromatography, Thin Layer Chromatography, Ion Chromatography); By End User (Pharmaceutical and Biotech Companies, CROs and CDMOs, Environmental Labs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chromatography Accessories and Consumables Market is projected to grow from $5.4 billion in 2024 to over $8 billion by 2030, with a steady CAGR of 5.9%, d... Read More

Published Date: NOV-2025 | No Of Pages:153 | $ 4485

Long-Acting Insulin Market By Product Type (Insulin Glargine, Insulin Detemir, Insulin Degludec, Others); By Application (Type 1 Diabetes, Type 2 Diabetes); By End User (Hospitals, Clinics, Home Care Settings, Diabetes Care Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Long-Acting Insulin Market is expected to expand from USD 32.6 billion in 2024 to USD 46.7 billion by 2030, growing at a CAGR of 5.3%, supported by demand... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Antibody-Mediated Rejection Prevention Market By Component (HLA & DSA Testing, Maintenance Immunosuppression, Desensitization Therapy, Plasma Exchange & IVIG, Transplant Biopsy, dd-cfDNA Testing, Targeted Biologics); By Organ Transplant Type (Kidney Transplants, Heart Transplants, Lung Transplants, Liver Transplants, Other Solid-Organ Transplants); By End User (Hospitals & Transplant Centers, Histocompatibility Laboratories, Specialty Diagnostic Laboratories, Apheresis & Infusion Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Antibody-Mediated Rejection Prevention Market: Rising Transplant Volumes, Diagnostic Surveillance, and Targeted Biologics Reshape Graft Protection

The Global Antibody-Mediated Rejection Prevention Market was valued at USD 215.00 billion in 2025 and is projected to rea... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Submucosal Lifting Agent Market By Product Type (Synthetic Agents, Natural Agents); By Application (Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, Polypectomy Assistance); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Endoscopy Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Submucosal Lifting Agent Market is projected to expand at a CAGR of 7.3% , climbing from an estimated $145 million in 2024 to reach $222 million by 2030 ,... Read More

Published Date: NOV-2025 | No Of Pages:179 | $ 4485

Hemostatic Gels Market By Product Type (Active Hemostatic Gels, Passive Hemostatic Gels); By Application (Surgical Wound Management, Trauma & Emergency Care, Dental Procedures, Neurosurgery); By End User (Hospitals, Ambulatory Surgical Centers, Military & Emergency Response Units, Dental Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemostatic Gels Market is projected to expand at a CAGR of 6.4% , reaching $1.62 billion by 2030 , up from an estimated $1.1 bill... Read More

Published Date: NOV-2025 | No Of Pages:160 | $ 4485

Progesterone Market By Product Type (Oral Tablets, Injectables, Topical Preparations); By Application (Infertility Treatment, Hormone Replacement Therapy, Other Applications); By End User (Fertility Clinics, Hospitals, Pharmaceutical Companies, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Progesterone Market will witness consistent expansion at a CAGR of 6.3%, growing from $4.6 billion in 2024 to $7.2 billion by 2030, supported by <... Read More

Published Date: NOV-2025 | No Of Pages:195 | $ 4485

CIS Insulin Market By Product Type (Human Insulin, Insulin Analogs [Basal, Prandial, Premixed]); By Route of Administration (Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The CIS Insulin Market will witness a robust CAGR of 6.43% , valued at USD 1.2 billion in 2024, expected to appreciate and reach USD 1.68 billion by... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Meningococcal Vaccines Market By Vaccine Type (Polysaccharide, Conjugate, Recombinant Protein-Based); By Serogroup Coverage (Monovalent, Bivalent, Quadrivalent, Pentavalent); By Distribution Channel (Public Health Agencies, Hospital Pharmacies, Retail Clinics); By End User (Hospitals, Pediatric Clinics, Military, Travel Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Meningococcal Vaccines Market will witness a robust CAGR of 8.4% , valued at $4.7 billion in 2024 , and is expected to appreciate and reach around $7.6 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Respiratory Syncytial Virus (RSV) Vaccine Market By Vaccine Type (Live Attenuated Vaccines, Subunit Vaccines, mRNA Vaccines, Vector-Based Vaccines, Others); By Target Population (Infants, Older Adults, Pregnant Women, High-Risk Adults, Others); By Route of Administration (Intramuscular, Intranasal, Subcutaneous, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Respiratory Syncytial Virus (RSV) Vaccine Market will grow at an impressive CAGR of 17.3%, increasing from $2.4 billion in 2024 to $6.3 billion by 2030, s... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Cancer Vaccines Market By Vaccine Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); By Disease Indication (Cervical Cancer, Prostate Cancer, Others); By End-User (Hospitals and Clinics, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer Vaccines Market is forecasted to surge from $8.5 billion in 2024 to $21.7 billion by 2030 at a 16.5% CAGR, supported by growth in oncology ... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Influenza Vaccine Market By Vaccine Type (Inactivated, Recombinant, Live Attenuated); By Age Group (Adults, Children, Elderly); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Influenza Vaccine Market will witness a robust CAGR of 5.1% , valued at $6.3 billion in 2024 , and is expected to appreciate to $8.9 billion by 2030 , con... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Carbapenem Market By Product Type (Meropenem, Imipenem-Cilastatin, Ertapenem, Doripenem, Others); By Indication (Respiratory Infections, UTIs, Intra-abdominal Infections, Sepsis, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Carbapenem Market will witness a robust CAGR of 5.8%, valued at USD 3.62 billion in 2024 and projected to reach USD 5.07 billion by 2030, driven by rising... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Genitourinary Drugs Market By Therapeutic Area (Genitourinary Oncology, Urinary Tract Infections and GU Anti-Infectives, Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms, Overactive Bladder and Urinary Incontinence, Erectile Dysfunction, Infertility and Reproductive Health, Genitourinary Syndrome of Menopause, Sexually Transmitted Infections, Other Genitourinary Conditions); By Drug Class (Antibiotics and Anti-Infectives, Hormonal and Androgen-Pathway Therapies, Immunotherapies and Targeted Oncology Drugs, Intravesical Agents, Alpha Blockers, 5-Alpha-Reductase Inhibitors, PDE5 Inhibitors, Antimuscarinics, Beta-3 Adrenergic Agonists, Fertility Hormones and Adjunctive Therapies, Other Drug Classes); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Genitourinary Drugs Market: GU Oncology Innovation, UTI Antibiotic Renewal, Chronic Urology Demand, and Sexual-Health Therapeutics Expand a Broad Specialty Drug Market

The Global Genitourinary Drugs Market will witness a robust 1.27% CAGR, valued at USD 31.2 billion i... Read More

Published Date: JUL-2026 | No Of Pages:200 | $ 4485

Subcutaneous Immunoglobulin Market By Product Type (Standard SCIG, High-Concentration SCIG); By Indication (Primary Immunodeficiency Diseases, Secondary Immunodeficiencies, Neurological Disorders, Other Autoimmune Disorders); By End User (Homecare Settings, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Subcutaneous Immunoglobulin (SCIG) Market will witness a robust CAGR of 8.9% , valued at approximately $6.4 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Shingles Vaccine Market By Vaccine Type (Recombinant Subunit, Live Attenuated); By Route of Administration (Intramuscular, Subcutaneous); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Public Health Agencies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Shingles Vaccine Market will witness a robust CAGR of 8.6% , valued at approximately $4.2 billion in 2024 , and is expected to appreciate and reach nearly $7.0 bil... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Medical Cannabis Market By Product Type (Flowers, Oils & Tinctures, Capsules, Edibles, Topicals); By Application (Chronic Pain, Neurology, Oncology, Mental Health Disorders, Others); By Route of Administration (Inhalation, Oral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Statistical Snapshot - Global Medical Cannabis Market (2024-2030)

  • The Global Medical Cannabis Market is valued at USD 21.3 billion in 2024 and is projected to reach USD 54.7 billion by 2030, expandi... Read More

    Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Biopharmaceutical Excipients Market By Product Type (Binders, Preservatives, Stabilizers, Emulsifiers, Solvents); By Application (Injectable Formulations, Oral Drug Formulations, Vaccines); By End User (Pharmaceutical Manufacturers, Contract Manufacturing Organizations [CMOs], Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Biopharmaceutical Excipients Market will experience a solid growth trajectory from USD 7.8 billion in 2024 to USD 11.5 billion by 2030 , reflecting a robust CAGR o... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Cannabis Extract Market By Extract Type (Full Spectrum, Broad Spectrum, Isolates); By Application (Pharmaceuticals, Food & Beverages, Personal Care, Recreational Use); By End User (Medical Users, Adult-Use Consumers, Industrial Buyers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Extract Market will witness a robust CAGR of 18.6%, valued at $12.4 billion in 2024, expected to appreciate and reach $34.2 billionRead More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485